PDGFRA — Targeted Therapies, Trials & Pipeline
PDGFRA mutations define a distinct GIST subgroup; the exon 18 D842V mutation is imatinib-resistant and requires frontline avapritinib.
PDGFRA mutations define a distinct GIST subgroup; the exon 18 D842V mutation is imatinib-resistant and requires frontline avapritinib.